Dow Down 0.21% Nasdaq Up 0.15%

Antares Pharma Inc. (ATRS)

-NasdaqCM
2.28 Down 0.07(2.98%) 11:50AM EDT - Nasdaq Real Time Price
Prev Close:2.35
Open:2.37
Bid:2.28 x 15500
Ask:2.29 x 5800
1y Target Est:5.33
Beta:0.85
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.28 - 2.37
52wk Range:1.87 - 5.15
Volume:642,380
Avg Vol (3m):1,321,670
Market Cap:297.47M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ATRS

Comparison

Symbol% ChgMkt Cap
ATRSDown 2.98%297.47M
BDXDown 0.35%22.40B
BJCT 0.00%7.12M

Key Statistics

Forward P/E (1 yr):45.60
P/S (ttm):14.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback